Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Biochemistry
|
October 8, 2003
Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase
Haoming Zhang, Larry Gruenke, Dave Arscott, et al.
Journal of Medicinal Chemistry
|
August 15, 2013
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A Perrey, Nadezhda A German, Brian P Gilmour, et al.
Journal of Medicinal Chemistry
|
June 8, 2021
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui Zhang, David A Perrey, Ann M Decker, et al.
American Journal of Cancer Research
|
March 25, 2017
Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
Fengzhi Li, Xiang Ling, Danni L Harris, et al.
European Journal of Medicinal Chemistry
|
September 20, 2022
Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects
Dehui Zhang, Ann M Decker, Kristen Woodhouse, et al.
Bioorganic & Medicinal Chemistry
|
May 20, 2021
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids
Thuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
ACS Chemical Neuroscience
|
December 12, 2023
Design, Synthesis, and Structure-Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold
Md Toufiqur Rahman, Dongliang Guan, Hetti Handi Chaminda Lakmal, et al.
Bioorganic & Medicinal Chemistry
|
July 29, 2015
The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A Perrey, Ann M Decker, Jun-Xu Li, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Development of Squaramides as Allosteric Modulators of the CB<sub>1</sub> Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats
Thuy Nguyen, Ann M Decker, Daniel G Barrus, et al.
ACS Chemical Neuroscience
|
July 25, 2017
Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists
Thuy Nguyen, Ann M Decker, Tiffany L Langston, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Biochemistry
|
October 8, 2003
Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase
Haoming Zhang, Larry Gruenke, Dave Arscott, et al.
Journal of Medicinal Chemistry
|
August 15, 2013
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A Perrey, Nadezhda A German, Brian P Gilmour, et al.
Journal of Medicinal Chemistry
|
June 8, 2021
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui Zhang, David A Perrey, Ann M Decker, et al.
American Journal of Cancer Research
|
March 25, 2017
Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
Fengzhi Li, Xiang Ling, Danni L Harris, et al.
European Journal of Medicinal Chemistry
|
September 20, 2022
Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects
Dehui Zhang, Ann M Decker, Kristen Woodhouse, et al.
Bioorganic & Medicinal Chemistry
|
May 20, 2021
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids
Thuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
ACS Chemical Neuroscience
|
December 12, 2023
Design, Synthesis, and Structure-Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold
Md Toufiqur Rahman, Dongliang Guan, Hetti Handi Chaminda Lakmal, et al.
Bioorganic & Medicinal Chemistry
|
July 29, 2015
The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A Perrey, Ann M Decker, Jun-Xu Li, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Development of Squaramides as Allosteric Modulators of the CB<sub>1</sub> Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats
Thuy Nguyen, Ann M Decker, Daniel G Barrus, et al.
ACS Chemical Neuroscience
|
July 25, 2017
Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists
Thuy Nguyen, Ann M Decker, Tiffany L Langston, et al.
Page
of 3